GHK-Cu is a tripeptide glycyl-L-histidyl-L-lysine complexed with a copper(II) ion
Is the Glow Blend FDA approved
Although a recent trial has shown to be beneficial when antiviral treatment is introduced early during the disease before hospitalization than later in the course of the disease, there is an urgent need for early therapies to reduce the risk of disease progression, prevent transmission, and be widely distributed to meet the worldwide demand (Gottlieb et al., 2022
According to the majority of the clinical trials, it is considered as a very common side effect of the medication
2017;77:113 Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A